The leading market experts have placed a mean price target of $141.59 on Laboratory Corporation of America Holdings (NYSE:LH) stock. This price level, which is estimated to be attained in one-year indicates the mean of stock opinions given by the companies included in the First Call survey. The renowned research firms have predicted earnings of $2.30 a share for the upcoming quarter and $8.79 for the current fiscal. Technical View The technical analysis of Laboratory Corporation of Ameri plainly substantiates that the 50-day moving average of Laboratory Corporation of Ameri is $127.82, and stock is hovering 0.60 or +0.47% distant from $127.82. It is noted that the 200-day MA is $118.90, and Laboratory Corporation of Ameri stock is $9.52 or +8.00% off from this point. Laboratory Corporation of America Holdings (NYSE:LH) 52-week high is $131.99 and the 52-week low is $97.79. This explains if the stock moves $-3.57, it will post a 52-week high. In event of $+31.32% points decline, a 52-week low will be hit. Taking the Valuation Aspect To emphasize the valuation of Laboratory Corporation of Ameri, shareholders can apply financial tool known as price-to-earnings ratio. This financial ratio assesses stock’s valuation by considering the relative expense of the stock. Following this ratio, Laboratory Corporation of America Holdings (NYSE:LH) ratio came in at 22.28. The stock last ended the trading session at $128.42 and registered a market cap of $13.15B. To appraise firm’s growth, the shareholders take help of the Price-to-Earnings-Growth ratio. When a stock has a higher PEG ratio, it is suggestive of lower stock appreciation in approaching sessions. A stock comes in the group of undervalued stocks when its PEG ratio falls in between 0 and 1. Laboratory Corporation of America Holdings (NYSE:LH) PEG ratio is at 1.46.
1 Chart Pattern Every Investor Should Know